Page 26 - ஐரோப்பிய தொழிற்சங்கம் நிதியுதவி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca vaccine can cause rare but unusual blood clots, European drug regulator says Print this article Drug regulators with the European Medicines Agency’s safety committee confirmed that the Oxford-AstraZeneca COVID-19 vaccine can cause blood clots with low blood platelets in some recipients. The European Union-funded agency said on Wednesday that the “unusual” blood clots should “be listed as very rare side effects” of the vaccine, adding that the vaccine is still effective at reducing COVID-19 hospitalizations and deaths. “EMA is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination,” the agency said in a

United statesEmer cookeEuropean medicines agencyDrug administrationEuropean union fundedExecutive director emer cookeஒன்றுபட்டது மாநிலங்களில்எமர் சமைக்கஐரோப்பிய தொழிற்சங்கம் நிதியுதவிநிர்வாகி இயக்குனர் எமர் சமைக்க